Discover open access scientific publications

A Phase II Study of Cyclophosphamide, Etoposide, Vincristine and Prednisone (CEOP) Alternating With Pralatrexate (P) as Front Line Therapy for Patients With Peripheral T-Cell Lymphoma (PTCL): Final Results From the T- Cell Consortium Trial